- TRADE NAMES: Chloraminophene; Leukeran (GSK); Linfolysin
- INDICATIONS: Chronic lymphocytic leukemia, lymphomas, carcinomas
- CLASS: Alkylating agent
- HALF-LIFE: 1.5 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aldesleukin, Antineoplastics, Azathioprine, Bone marrow suppressants, Prednisone, Vaccines
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
